FDA-Approved Ruxolitinib in Patients with Myelofibrosis: the Stanford Experience

被引：0

|

作者：

Nguyen, Huong ^{[1
]}

Anh Pham ^{[1
]}

Perkins, Cecelia ^{[1
]}

Linder, Andrea ^{[1
]}

Fechter, Lenn ^{[1
]}

Gotlib, Jason ^{[1
]}

机构：

[1] Stanford Univ, Sch Med, Stanford, CA 94305 USA

来源：

BLOOD | 2012年 / 120卷 / 21期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

1747

引用

收藏

页数：2

相关论文

共 50 条

[31] The First FDA-Approved Batches of Botox®
Johnson, Eric A.
TOXICON, 2022, 214 : S28 - S28
[32] Recent changes to FDA-approved labeling
不详
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2005, 62 (01) : 33 - 33
[33] Recent changes to FDA-approved labeling
不详
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2003, 60 (06) : 544 - 544
[34] Recent changes to FDA-approved labeling
不详
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2004, 61 (15) : 1537 - 1537
[35] FDA-approved drug promotes remyelination
Sarah Lempriere
Nature Reviews Neurology, 2022, 18 : 637 - 637
[36] Recent changes to FDA-approved labeling
不详
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2002, 59 (18) : 1714 - 1714
[37] Recently FDA-approved drug: A new hope for vitiligo patients?
Siddiq, Mohammad Arham
Obaid, Muhammad Adil
Zaidi, Syeda Dua E. Zehra
Azam, Syed Talal
Rangwala, Burhanuddin
ANNALS OF MEDICINE AND SURGERY, 2022, 82
[38] Trends in FDA-Approved Cancer Therapies
Hilas, Olga
US PHARMACIST, 2023, 48 (10) : 14 - 14
[39] Recent changes to FDA-approved labeling
不详
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2003, 60 (22) : 2294 - 2294
[40] Recent changes to FDA-approved labeling
不详
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2005, 62 (10) : 1004 - 1004

← 1 2 3 4 5 →